As part of the partnership, Sunquest will work closely with and invest in GeneInsight, a company focused on developing IT platforms that streamline genetic testing analysis, and a company of which Partners HealthCare is a majority shareholder.
The goal is to develop a platform that will better integrate genomic information into clinical decisionmaking. “With this relationship we will be able to bring new genomic knowledge to treating clinicians much more rapidly, advancing the field of personalized medicine and ensuring that our patients, and patients worldwide, will benefit from the most up-to-date genomic information available at the point of care,” said Anne Klibanski, MD, chief academic officer at Partners HealthCare.
More articles on personalized medicine:
What current investment, M&A rates reveal about the health IT market
NIH: 10k Clinical Genome Tests Will be Ordered in 2014, Even More in 2015
10 Disruptive Forces in Healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.